XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash and cash equivalents $ 4,290,198 $ 16,612,711
Accounts receivable, net 394,570 493,113
Inventory, net 271,137 227,437
Current portion of mortgage note receivable 0 45,977
Prepaid insurance and services 115,889 42,246
Prepaid clinical expenses 3,350,002 2,014,851
Total current assets 8,421,796 19,436,335
FURNITURE AND EQUIPMENT, NET 60,058 59,583
RIGHT-TO-USE LEASE ASSET, NET 5,669 17,636
MORTGAGE NOTE RECEIVABLE, LESS CURRENT PORTION 0 7,279
TOTAL ASSETS 8,487,523 19,520,833
CURRENT LIABILITIES    
Current portion of lease liability 4,978 19,245
Current portion of note payable 0 133,712
Accounts payable and accrued expenses 2,870,085 3,677,979
Total current liabilities 2,875,063 3,830,936
LONG-TERM LIABILITIES    
Long-term note payable, less current portion 0 18,034
STOCKHOLDERS' EQUITY    
Common stock, par value $.0001 per share, 20,000,000 shares authorized, 8,455,452 and 8,403,869 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively 846 841
Preferred stock, par value $.0001 per share, 5,000,000 shares authorized, 0 issued and outstanding 0 0
Additional paid-in capital 64,430,566 64,019,513
Accumulated deficit (58,818,952) (48,348,491)
Total stockholders' equity 5,612,460 15,671,863
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 8,487,523 $ 19,520,833